Results 71 to 80 of about 3,978,530 (165)

Researchers’ Experiences with IRB Oversight of Psychedelic Research

open access: yesEthics &Human Research, Volume 48, Issue 6, Page 6-19, November–December 2026.
ABSTRACT Previous research raises concern that conservative institutional review board (IRB) approaches regarding stigmatized issues and vulnerable groups could similarly arise as an impediment to research with psychedelic drugs. We interviewed 20 US researchers who had been a principal investigator on at least one research protocol involving ...
Logan Neitzke‐Spruill   +5 more
wiley   +1 more source

Obsessive–Compulsive Disorder: Comorbidity, Biomarkers, Circuits, and Treatment Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
OCD has a high comorbidity with other psychiatric conditions, among which anxiety is the most frequent one. The shared genetic biomarkers and common neural circuits underlying the co‐occurrence of OCD and anxiety pave a new path for understanding the pathogenic mechanism of OCD and suggest tailored and integrative treatment therapies for OCD from the ...
Xiao‐Yang Zhang   +9 more
wiley   +1 more source

Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration

open access: yesAging Cell, Volume 25, Issue 11, November 2026.
Lysergic acid diethylamide (LSD) induces transcriptional programmes in the rodent prefrontal cortex that oppose signatures of human brain ageing and neurodegeneration. In primary cortical cultures, LSD also attenuates amyloid‐β‐induced alterations. Consistent with the signature reversion principle, these findings provide a data‐driven rationale for ...
Aurora Savino   +9 more
wiley   +1 more source

After the Trip: A Qualitative Study of Healthy Individuals’ Motor Experiences Following Different Doses of Psilocybin

open access: yesBrain and Behavior, Volume 16, Issue 10, October 2026.
ABSTRACT Introduction Psilocybin is a naturally occurring classic psychedelic associated with widespread changes in brain function and promising therapeutic outcomes in several neuropsychiatric disorders. Complementing these findings, qualitative studies following psilocybin administration have revealed diverse and highly individual effects across ...
Ruiqi Rachel Luo   +5 more
wiley   +1 more source

Narrative therapy-assisted psilocybin use for treatment of depression

open access: yes, 2017
There is recent renewed interest in use of psychedelic drugs for treatment of psychiatric disorders, including serotonin agonists such as psilocybin, potentially providing a new approach to treatment.
Delavan, Carlyn
core  

Mystical experiences mediate the effects of psilocybin-assisted psychotherapy + mindfulness-based stress reduction on trait mindfulness and depression symptoms: mechanistic results from a randomized controlled trial

open access: yesJournal of Affective Disorders Reports
Background: Healthcare workers experienced amplified depression and burnout during COVID-19. Both Mindfulness Based Stress Reduction (MBSR) and psilocybin have been shown to reduce depressive symptoms in this population, however the psychological ...
Kevin Byrne   +3 more
doaj   +1 more source

Acute ayahuasca administration attenuates binge‐like eating and anxiety‐related behaviors in mice subjected to intermittent fasting

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Human binge eating disorder is characterized by recurrent episodes of excessive food consumption accompanied by loss of control and is strongly associated with alterations in reward processing and emotional regulation. Ayahuasca, a psychoactive botanical preparation traditionally used in Amazonian medicine, has been shown to modulate ...
Cristian Ferreira Corona   +10 more
wiley   +1 more source

“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin‐assisted psychotherapy

open access: yes, 2023
OBJECTIVE: This study invited providers who care for patients with eating disorders to inform engagement, communication, and collaboration with psilocybin-assisted psychotherapy interventions.
Amanda E. Downey   +12 more
core   +1 more source

Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.

open access: yesPLoS ONE
BackgroundPosttraumatic stress disorder (PTSD) affects 3.9% of the general population. While massed cognitive processing therapy (CPT) has demonstrated efficacy in treating chronic PTSD, a substantial proportion of patients still continue to meet PTSD ...
Shakila Meshkat   +7 more
doaj   +1 more source

Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care

open access: yesPalliative Medicine Reports
Psilocybin-assisted psychotherapy represents a promising addition to palliative care interventions, potentially improving quality of life by addressing existential distress.
Michel Dorval   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy